Use of SV40 to Immunize Against Hepatitis B Surface Antigen: Implications for the Use of SV40 for Gene Transduction and Its Use as an Immunizing Agent
Gene Therapy - United Kingdom
doi 10.1038/sj.gt.3300623
Full Text
Open PDFAbstract
Available in full text
Date
May 1, 1998
Authors
Publisher
Springer Science and Business Media LLC